Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.48 +0.03 (+1.22%)
At close: Nov 11, 2026 · 4:00 PM EST

Rocket Pharmaceuticals (RCKT) Net Long-Term Debt Issued (Repaid) (2014 - 2015)

Updated

Rocket Pharmaceuticals' Non-Current Debt was $2.55 million in Q4 2014.

Analysis

Rocket Pharmaceuticals (RCKT) Net Long-Term Debt Issued (Repaid) (2014 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Rocket Pharmaceuticals 268.37 Mn -15.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 15.20 Mn
Dec 31, 2014 -715,000.00
API Access

Rocket Pharmaceuticals Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=RCKT&period=max&api_key=YOUR_API_KEY